Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn's Disease.
Alexdottir MS, Bourgonje AR, Karsdal MA, Pehrsson M, Loveikyte R, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, Faber KN, Dijkstra G, Mortensen JH. Alexdottir MS, et al. Front Med (Lausanne). 2022 Jul 12;9:933872. doi: 10.3389/fmed.2022.933872. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35903311 Free PMC article.
Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease.
Bourgonje AR, Alexdottir MS, Otten AT, Loveikyte R, Bay-Jensen AC, Pehrsson M, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, Karsdal MA, Faber KN, Mortensen JH, Dijkstra G. Bourgonje AR, et al. Among authors: alexdottir ms. Aliment Pharmacol Ther. 2022 Aug;56(4):675-693. doi: 10.1111/apt.17063. Epub 2022 Jun 6. Aliment Pharmacol Ther. 2022. PMID: 35661188 Free PMC article.
Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn's Disease.
Alexdottir MS, Bourgonje AR, Karsdal MA, Pehrsson M, Loveikyte R, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, Faber KN, Dijkstra G, Mortensen JH. Alexdottir MS, et al. Int J Mol Sci. 2022 Jul 23;23(15):8137. doi: 10.3390/ijms23158137. Int J Mol Sci. 2022. PMID: 35897710 Free PMC article.